Mester, P.; Räth, U.; Schmid, S.; Amend, P.; Keller, D.; Krautbauer, S.; Bondarenko, S.; Müller, M.; Buechler, C.; Pavel, V.
Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity. Biomedicines 2024, 12, 125.
https://doi.org/10.3390/biomedicines12010125
AMA Style
Mester P, Räth U, Schmid S, Amend P, Keller D, Krautbauer S, Bondarenko S, Müller M, Buechler C, Pavel V.
Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity. Biomedicines. 2024; 12(1):125.
https://doi.org/10.3390/biomedicines12010125
Chicago/Turabian Style
Mester, Patricia, Ulrich Räth, Stephan Schmid, Pablo Amend, Dennis Keller, Sabrina Krautbauer, Sofiia Bondarenko, Martina Müller, Christa Buechler, and Vlad Pavel.
2024. "Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity" Biomedicines 12, no. 1: 125.
https://doi.org/10.3390/biomedicines12010125
APA Style
Mester, P., Räth, U., Schmid, S., Amend, P., Keller, D., Krautbauer, S., Bondarenko, S., Müller, M., Buechler, C., & Pavel, V.
(2024). Serum Insulin-like Growth Factor-Binding Protein-2 as a Prognostic Factor for COVID-19 Severity. Biomedicines, 12(1), 125.
https://doi.org/10.3390/biomedicines12010125
